Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$46.88
-0.65-1.37%
At close: -
$46.92
0.040.09%
After Hours: 4:13 PM EDT
Comments
Loading...
Nutrien Analyst Ratings and Price Targets | NYSE:NTR | Benzinga
Nutrien Ltd has a consensus price target of $66 based on the ratings of 30 analysts. The high is $91 issued by Morgan Stanley on January 11, 2023. The low is $50 issued by JP Morgan on January 13, 2025. The 3 most-recent analyst ratings were released by Goldman Sachs, Barclays, and CIBC on March 13, 2025, March 5, 2025, and February 25, 2025, respectively. With an average price target of $59.33 between Goldman Sachs, Barclays, and CIBC, there's an implied 26.56% upside for Nutrien Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Goldman Sachs
Barclays
CIBC
RBC Capital
Scotiabank
1calculated from analyst ratings
Analyst Ratings for Nutrien
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/13/2025 | Buy Now | 13.05% | Goldman Sachs | Duffy Fischer59% | → $53 | Initiates | → Sell | Get Alert |
| 03/05/2025 | Buy Now | 25.85% | Barclays | Benjamin Theurer61% | $56 → $59 | Maintains | Equal-Weight | Get Alert |
| 02/25/2025 | Buy Now | 40.78% | CIBC | — | $64 → $66 | Maintains | Outperformer | Get Alert |
| 02/24/2025 | Buy Now | 27.99% | RBC Capital | Andrew Wong38% | $60 → $60 | Reiterates | Outperform → Outperform | Get Alert |
| 02/24/2025 | Buy Now | 32.25% | Scotiabank | Ben Isaacson44% | $60 → $62 | Maintains | Sector Outperform | Get Alert |
| 02/21/2025 | Buy Now | 19.45% | Wells Fargo | Richard Garchitorena42% | $53 → $56 | Maintains | Equal-Weight | Get Alert |
| 02/20/2025 | Buy Now | 17.32% | Mizuho | Christopher Parkinson57% | $52 → $55 | Maintains | Neutral | Get Alert |
| 02/20/2025 | Buy Now | 15.19% | UBS | Eric Beaumont72% | $53 → $54 | Maintains | Neutral | Get Alert |
| 02/10/2025 | Buy Now | 27.99% | Scotiabank | Ben Isaacson44% | $59 → $60 | Maintains | Sector Outperform | Get Alert |
| 01/28/2025 | Buy Now | 13.05% | UBS | Joshua Spector54% | $51 → $53 | Maintains | Neutral | Get Alert |
| 01/28/2025 | Buy Now | 13.05% | Wells Fargo | Richard Garchitorena42% | $52 → $53 | Maintains | Equal-Weight | Get Alert |
| 01/27/2025 | Buy Now | 34.39% | Piper Sandler | Charles Neivert47% | $58 → $63 | Maintains | Overweight | Get Alert |
| 01/21/2025 | Buy Now | 19.45% | Barclays | Benjamin Theurer61% | $55 → $56 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/13/2025 | Buy Now | 23.72% | Piper Sandler | Charles Neivert47% | $50 → $58 | Upgrade | Underweight → Overweight | Get Alert |
| 01/13/2025 | Buy Now | 6.66% | JP Morgan | Jeffrey Zekauskas68% | $40 → $50 | Upgrade | Underweight → Neutral | Get Alert |
| 12/12/2024 | Buy Now | 27.99% | Oppenheimer | Kristen Owen45% | → $60 | Initiates | → Outperform | Get Alert |
| 12/10/2024 | Buy Now | 17.32% | CIBC | — | $60 → $55 | Assumes | → Outperformer | Get Alert |
| 12/03/2024 | Buy Now | 27.99% | Raymond James | Steve Hansen61% | $58 → $60 | Upgrade | Market Perform → Outperform | Get Alert |
| 10/10/2024 | Buy Now | 8.79% | UBS | Joshua Spector54% | $66 → $51 | Downgrade | Buy → Neutral | Get Alert |
| 09/24/2024 | Buy Now | 6.66% | Wells Fargo | Richard Garchitorena42% | $62 → $50 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 09/20/2024 | Buy Now | 27.99% | RBC Capital | Andrew Wong38% | $60 → $60 | Reiterates | Outperform → Outperform | Get Alert |
| 09/10/2024 | Buy Now | 13.05% | Goldman Sachs | Adam Samuelson63% | $69 → $53 | Downgrade | Buy → Neutral | Get Alert |
| 08/16/2024 | Buy Now | 17.32% | Barclays | Benjamin Theurer61% | $68 → $55 | Maintains | Overweight | Get Alert |
| 08/12/2024 | Buy Now | 27.99% | RBC Capital | Andrew Wong38% | $60 → $60 | Reiterates | Outperform → Outperform | Get Alert |
| 08/12/2024 | Buy Now | 25.85% | Scotiabank | Ben Isaacson44% | $66 → $59 | Maintains | Sector Outperform | Get Alert |
| 08/09/2024 | Buy Now | 59.98% | BMO Capital | Joel Jackson50% | $80 → $75 | Maintains | Outperform | Get Alert |
| 08/08/2024 | Buy Now | 10.92% | Mizuho | Christopher Parkinson57% | $55 → $52 | Maintains | Neutral | Get Alert |
| 07/16/2024 | Buy Now | 40.78% | Wells Fargo | Richard Garchitorena42% | $68 → $66 | Maintains | Overweight | Get Alert |
| 07/15/2024 | Buy Now | 27.99% | RBC Capital | Andrew Wong38% | $70 → $60 | Maintains | Outperform | Get Alert |
| 07/09/2024 | Buy Now | 40.78% | UBS | Joshua Spector54% | $67 → $66 | Maintains | Buy | Get Alert |
| 06/11/2024 | Buy Now | 17.32% | Piper Sandler | Charles Neivert47% | $56 → $55 | Maintains | Underweight | Get Alert |
| 05/17/2024 | Buy Now | 19.45% | Piper Sandler | Charles Neivert47% | $54 → $56 | Maintains | Underweight | Get Alert |
| 05/17/2024 | Buy Now | 19.45% | Mizuho | Christopher Parkinson57% | $54 → $56 | Maintains | Underweight | Get Alert |
| 05/10/2024 | Buy Now | 45.05% | Wells Fargo | Richard Garchitorena42% | $67 → $68 | Maintains | Overweight | Get Alert |
| 05/09/2024 | Buy Now | 25.85% | Mizuho | Christopher Parkinson57% | $54 → $59 | Maintains | Neutral | Get Alert |
| 04/29/2024 | Buy Now | 40.78% | Berenberg | Aron Ceccarelli10% | $60 → $66 | Upgrade | Hold → Buy | Get Alert |
| 03/26/2024 | Buy Now | 32.25% | Jefferies | Laurence Alexander75% | → $62 | Initiates | → Buy | Get Alert |
| 03/01/2024 | Buy Now | — | Wolfe Research | Chris Parkinson80% | — | Initiates | → Outperform | Get Alert |
| 02/29/2024 | Buy Now | 15.19% | Piper Sandler | Charles Neivert47% | $68 → $54 | Downgrade | Neutral → Underweight | Get Alert |
| 02/26/2024 | Buy Now | 47.18% | Wells Fargo | Richard Garchitorena42% | $77 → $69 | Maintains | Overweight | Get Alert |
| 02/23/2024 | Buy Now | 49.32% | RBC Capital | Andrew Wong38% | $75 → $70 | Maintains | Outperform | Get Alert |
| 02/23/2024 | Buy Now | 2.39% | JP Morgan | Jeffrey Zekauskas68% | $58 → $48 | Downgrade | Neutral → Underweight | Get Alert |
| 02/01/2024 | Buy Now | 66.38% | Goldman Sachs | Adam Samuelson63% | $88 → $78 | Maintains | Buy | Get Alert |
| 01/19/2024 | Buy Now | 59.98% | Stifel | Vincent Anderson73% | $72 → $75 | Maintains | Buy | Get Alert |
| 01/12/2024 | Buy Now | 38.65% | Raymond James | Steve Hansen61% | $80 → $65 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/14/2023 | Buy Now | 45.05% | Barclays | Benjamin Theurer61% | $64 → $68 | Upgrade | Underweight → Overweight | Get Alert |
| 11/06/2023 | Buy Now | 23.72% | JP Morgan | Jeffrey Zekauskas68% | $70 → $58 | Downgrade | Overweight → Neutral | Get Alert |
| 11/03/2023 | Buy Now | 70.65% | RBC Capital | Andrew Wong38% | $85 → $80 | Maintains | Outperform | Get Alert |
| 08/14/2023 | Buy Now | 45.05% | Barclays | Benjamin Theurer61% | $70 → $68 | Downgrade | Overweight → Underweight | Get Alert |
| 08/08/2023 | Buy Now | 81.31% | RBC Capital | Andrew Quail32% | → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 08/07/2023 | Buy Now | 55.72% | Piper Sandler | Charles Neivert47% | $70 → $73 | Maintains | Neutral | Get Alert |
| 08/04/2023 | Buy Now | 55.72% | Mizuho | Christopher Parkinson57% | $74 → $73 | Maintains | Neutral | Get Alert |
| 07/31/2023 | Buy Now | 77.05% | TD Cowen | Michael Tupholme41% | $72 → $83 | Upgrade | Hold → Buy | Get Alert |
| 07/26/2023 | Buy Now | 53.58% | HSBC | Santhosh Seshadri71% | $81 → $72 | Maintains | Hold | Get Alert |
| 07/25/2023 | Buy Now | 49.32% | Morgan Stanley | Vincent Sinisi74% | $70 → $70 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/24/2023 | Buy Now | 74.91% | Wells Fargo | Richard Garchitorena42% | $62 → $82 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 07/19/2023 | Buy Now | 49.32% | Morgan Stanley | Vincent Sinisi74% | $70 → $70 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/18/2023 | Buy Now | 158.11% | Goldman Sachs | Adam Samuelson63% | $136 → $121 | Maintains | Buy | Get Alert |
| 06/08/2023 | Buy Now | 81.31% | B of A Securities | Steve Byrne54% | $94 → $85 | Maintains | Buy | Get Alert |
| 06/01/2023 | Buy Now | 49.32% | Barclays | Benjamin Theurer61% | $80 → $70 | Maintains | Overweight | Get Alert |
| 05/30/2023 | Buy Now | 49.32% | Morgan Stanley | Vincent Sinisi74% | $80 → $70 | Maintains | Equal-Weight | Get Alert |
| 05/19/2023 | Buy Now | 66.38% | JP Morgan | Jeffrey Zekauskas68% | $92 → $78 | Maintains | Overweight | Get Alert |
| 05/18/2023 | Buy Now | 49.32% | Piper Sandler | Charles Neivert47% | $82 → $70 | Maintains | Neutral | Get Alert |
| 05/17/2023 | Buy Now | 4.52% | Berenberg | Aron Ceccarelli10% | $92 → $49 | Downgrade | Buy → Hold | Get Alert |
| 05/16/2023 | Buy Now | 91.98% | BMO Capital | Joel Jackson50% | $110 → $90 | Maintains | Outperform | Get Alert |
| 05/15/2023 | Buy Now | 32.25% | Wells Fargo | Richard Garchitorena42% | $82 → $62 | Maintains | Equal-Weight | Get Alert |
| 05/12/2023 | Buy Now | 102.65% | RBC Capital | Andrew Quail32% | $100 → $95 | Maintains | Outperform | Get Alert |
| 05/12/2023 | Buy Now | 81.31% | Raymond James | Steve Hansen61% | → $85 | Upgrade | Market Perform → Outperform | Get Alert |
| 05/12/2023 | Buy Now | 59.98% | Mizuho | Christopher Parkinson57% | $79 → $75 | Maintains | Neutral | Get Alert |
| 05/12/2023 | Buy Now | 70.65% | Barclays | Benjamin Theurer61% | $93 → $80 | Maintains | Overweight | Get Alert |
| 05/11/2023 | Buy Now | 27.99% | Credit Suisse | Edlain Rodriguez65% | $70 → $60 | Reiterates | Underperform → Underperform | Get Alert |
| 04/19/2023 | Buy Now | 126.11% | Goldman Sachs | Adam Samuelson63% | $119 → $106 | Maintains | Buy | Get Alert |
| 04/14/2023 | Buy Now | 98.38% | Barclays | Benjamin Theurer61% | $95 → $93 | Maintains | Overweight | Get Alert |
| 04/12/2023 | Buy Now | 70.65% | Morgan Stanley | Vincent Sinisi74% | $91 → $80 | Maintains | Equal-Weight | Get Alert |
| 04/10/2023 | Buy Now | 91.98% | Scotiabank | Ben Isaacson44% | $95 → $90 | Upgrade | Sector Perform → Sector Outperform | Get Alert |
| 04/06/2023 | Buy Now | 111.18% | UBS | Joshua Spector54% | $100 → $99 | Maintains | Buy | Get Alert |
| 03/28/2023 | Buy Now | — | Erste Group | Hans Engel58% | — | Downgrade | Buy → Hold | Get Alert |
| 02/23/2023 | Buy Now | 96.25% | JP Morgan | Jeffrey Zekauskas68% | → $92 | Maintains | Overweight | Get Alert |
| 02/21/2023 | Buy Now | 134.64% | RBC Capital | Andrew Quail32% | $115 → $110 | Maintains | Outperform | Get Alert |
| 02/21/2023 | Buy Now | 72.78% | HSBC | Santhosh Seshadri71% | $83 → $81 | Maintains | Hold | Get Alert |
| 02/17/2023 | Buy Now | 74.91% | Wells Fargo | Richard Garchitorena42% | $80 → $82 | Maintains | Equal-Weight | Get Alert |
| 02/16/2023 | Buy Now | 113.31% | UBS | Joshua Spector54% | $103 → $100 | Maintains | Buy | Get Alert |
| 02/16/2023 | Buy Now | 49.32% | Credit Suisse | Edlain Rodriguez65% | $65 → $70 | Maintains | Underperform | Get Alert |
| 02/08/2023 | Buy Now | — | TD Securities | Michael Tupholme41% | — | Downgrade | Buy → Hold | Get Alert |
| 02/03/2023 | Buy Now | — | Raymond James | Steve Hansen61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/30/2023 | Buy Now | 145.31% | RBC Capital | Andrew Wong38% | $120 → $115 | Maintains | Outperform | Get Alert |
| 01/20/2023 | Buy Now | 83.45% | Citigroup | PJ Juvekar70% | $87 → $86 | Maintains | Buy | Get Alert |
| 01/19/2023 | Buy Now | 70.65% | Wells Fargo | Richard Garchitorena42% | → $80 | Initiates | → Equal-Weight | Get Alert |
| 01/13/2023 | Buy Now | 102.65% | JP Morgan | Jeffrey Zekauskas68% | $98 → $95 | Maintains | Overweight | Get Alert |
| 01/12/2023 | Buy Now | 94.11% | Mizuho | Christopher Parkinson57% | $93 → $91 | Maintains | Neutral | Get Alert |
| 01/11/2023 | Buy Now | 119.71% | UBS | Joshua Spector54% | $110 → $103 | Maintains | Buy | Get Alert |
| 01/11/2023 | Buy Now | 94.11% | Morgan Stanley | Vincent Andrews78% | $100 → $91 | Maintains | Equal-Weight | Get Alert |
| 01/09/2023 | Buy Now | — | Credit Suisse | Edlain Rodriguez65% | — | Assumes | → Underperform | Get Alert |
| 11/30/2022 | Buy Now | 98.38% | Piper Sandler | Charles Neivert47% | $115 → $93 | Downgrade | Overweight → Neutral | Get Alert |
| 11/17/2022 | Buy Now | 102.65% | Barclays | Benjamin Theurer61% | $105 → $95 | Maintains | Overweight | Get Alert |
| 11/07/2022 | Buy Now | 155.97% | RBC Capital | Andrew Wong38% | $135 → $120 | Maintains | Outperform | Get Alert |
| 11/04/2022 | Buy Now | 109.04% | JP Morgan | Jeffrey Zekauskas68% | → $98 | Maintains | Overweight | Get Alert |
| 11/04/2022 | Buy Now | 98.38% | Mizuho | Christopher Parkinson57% | $113 → $93 | Maintains | Neutral | Get Alert |
| 11/04/2022 | Buy Now | 134.64% | BMO Capital | Joel Jackson50% | $115 → $110 | Maintains | Outperform | Get Alert |
| 11/03/2022 | Buy Now | 45.05% | Credit Suisse | John Roberts74% | $70 → $68 | Maintains | Underperform | Get Alert |
FAQ
What is the target price for Nutrien (NTR) stock?
The latest price target for Nutrien (NYSE:NTR) was reported by Goldman Sachs on March 13, 2025. The analyst firm set a price target for $53.00 expecting NTR to rise to within 12 months (a possible 13.05% upside). 36 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Nutrien (NTR)?
The latest analyst rating for Nutrien (NYSE:NTR) was provided by Goldman Sachs, and Nutrien initiated their sell rating.
When was the last upgrade for Nutrien (NTR)?
The last upgrade for Nutrien Ltd happened on January 13, 2025 when Piper Sandler raised their price target to $58. Piper Sandler previously had an underweight for Nutrien Ltd.
When was the last downgrade for Nutrien (NTR)?
The last downgrade for Nutrien Ltd happened on January 21, 2025 when Barclays changed their price target from $55 to $56 for Nutrien Ltd.
When is the next analyst rating going to be posted or updated for Nutrien (NTR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nutrien, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nutrien was filed on March 13, 2025 so you should expect the next rating to be made available sometime around March 13, 2026.
Is the Analyst Rating Nutrien (NTR) correct?
While ratings are subjective and will change, the latest Nutrien (NTR) rating was a initiated with a price target of $0.00 to $53.00. The current price Nutrien (NTR) is trading at is $46.88, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.